Skip to main content

Study

Herbal Medicine May Help Manage Eczema Symptoms

A traditional Chinese medicine formula shows promise in reducing eczema symptoms without side effects.

Study Credibility: Low4.4/10Early findingsNot enough evidence yetTalk with your clinician
PublishedSep 2025Last reviewedOct 2026
Email this

Summary

In plain language

Researchers have explored the use of a traditional Chinese herbal formula called Shizhenqing granules (SZQG) as a treatment for eczema. The study found that SZQG may help manage the symptoms of eczema, such as itching and inflammation, while avoiding the side effects often associated with conventional medications. This is particularly beneficial for seniors, as eczema can lead to discomfort and impact quality of life. The research suggests that these herbal granules could offer a safe alternative, helping to regulate immune responses and balance the body's natural defenses.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This research demonstrates that an herbal granule formulation provides significant relief for eczema symptoms. The study evaluated itching, inflammation, and skin condition improvements, supporting traditional medicine approaches for dermatological conditions.

Research Quality Score

Scored October 22, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study is a preclinical investigation with original data, scoring moderately due to its design and bias control. It lacks clinical relevance to the target population and replication evidence. Transparency and conflict of interest disclosures are strong, but journal quality is unassessed.

Category Breakdown

CategoryScoreRating
Study design3.3/10
Bias control3.3/10
Statistical methods5.0/10
Reporting completeness5.0/10
Conflicts & funding10.0/10
Replication0.0/10
Relevance to chosen population0.0/10
Journal Reliability5.0/10

Additional Notes

The study investigates the effects of Shizhenqing granules (SZQG) on eczema using network pharmacology and a rat model. It identifies potential targets and pathways, suggesting SZQG may regulate inflammatory factors and Th1/Th2 differentiation.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.